CGRP inhibitors, both the injectable preventive versions and the oral acute treatments, do not interact with tirzepatide pharmacologically
Together, these risk factors converge on the common pathways of chronic liver injury, inflammation, regeneration, and fibrosis/cirrhosis, ultimately setting the stage for malignant transformation
As absorption is impaired, many of you feel drastically better with B12 injections or IV nutrient therapy
The results were clear
Potential issues include: Pain, redness, or bruising at the injection site Small but real risk of infection or phlebitis at the IV site Temporary flushing, nausea, or lightheadedness during infusion Rare allergic reactions to glutathione or other components in the IV mix For this reason, glutathione injections are best reserved for people who are under active clinical care and have a clear indication for high-dose or systemic therapy